Product Information

METHYLERGONOVINE 0.2 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $4.3506 per EA under NDC 00904728210. Its NADAC has been published 87 times since Dec 25, 2024.

FDA first approved this application on May 15, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METHYLERGONOVINE 0.2 MG TABLET

Methylergonovine Maleate
$4.3506per EA

Strength

.2 mg/1

NDC

00904728210

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

METHYLERGONOVINE MALEATE

Approval Type

Generic (ANDA)

FDA Application

ANDA210424

FDA Approved

5/15/2018

TE Code

AB

On Market Since

9/13/2024

Pharmacological Classes

Price Statistics

The NADAC for METHYLERGONOVINE 0.2 MG TABLET has been published 87 times since Dec 25, 2024, and over the history we have for it it has declined 44.9%. The table below summarizes its recorded NADAC range and movement.

Current price$4.3506 per EA
All-time high$7.8925 (Jan 15, 2025)
All-time low$4.3506 (Aug 19, 2026)
52-week high$5.9732
52-week low$4.3506
Median price$5.6609
Average price$5.8593
Largest weekly change-11.5% (Jul 22, 2026)
Weeks tracked87
Tracking sinceDec 25, 2024

Price History

1W

-1.9%

1M

-1.9%

3M

-21.1%

6M

-17.9%

1Y

-27.2%

3Y

N/A

5Y

N/A

All

-44.9%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of METHYLERGONOVINE 0.2 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for METHYLERGONOVINE 0.2 MG TABLET, manufactured by Major Pharmaceuticals, is $4.3506 per EA (NDC 00904728210), effective Aug 19, 2026.

How has the price of METHYLERGONOVINE 0.2 MG TABLET changed over time?

Over the history we have for it, the NADAC for METHYLERGONOVINE 0.2 MG TABLET has declined 44.9%. It has been tracked across 87 weekly CMS publications since Dec 25, 2024.

What are the highest and lowest recorded NADAC prices for METHYLERGONOVINE 0.2 MG TABLET?

Since Dec 25, 2024, the NADAC for METHYLERGONOVINE 0.2 MG TABLET has ranged from a low of $4.3506 (Aug 19, 2026) to a high of $7.8925 (Jan 15, 2025), with a median of $5.6609 per EA.

Are there cheaper alternatives to METHYLERGONOVINE 0.2 MG TABLET?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHYLERGONOVINE 0.2 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures METHYLERGONOVINE 0.2 MG TABLET?

METHYLERGONOVINE 0.2 MG TABLET (NDC 00904728210) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.